一个随机对照试验的移动应用程序干预,用于肥胖患者和一般实践中超重患者:用户参与度分析量化研究
Vera Helen Buss1, Margo Barr1, Sharon M Parker1
1Centre for Primary Health Care and Equity, University of New South Wales, Sydney, Australia.
JMIR mHealth and uHealth
|February 9, 2024
概括
这项研究发现,虽然mysnapp移动应用程序没有直接改善健康素养或饮食,但应用程序用户更有可能参与其他健康干预措施. 这表明参与者使用减肥计划的多个组件的承诺增加了.
科学领域:
- 公共卫生 公共卫生
- 健康 行为 改变 改变
- 数字健康干预措施 数字健康干预措施
背景情况:
- 一般实践中的预防健康电子识字试验针对来自社会经济水平较低,健康素养较低的超重和肥胖个体.
- 这些人口面临着糖尿病和心血管疾病等慢性疾病的高风险.
- 该干预包括实践护士访问,移动应用程序 (mysnapp) 和电话辅导.
研究的目的:
- 在减肥干预中评估移动应用 (mysnapp) 使用模式.
- 检查应用程序使用与其他干预组件的关联,并研究结果.
- 为了确定健康素养和饮食是否在6个月后显著改善.
主要方法:
- 一个集群随机试验,涉及澳大利亚22个普通诊所.
- 干预包括健康检查,生活方式应用程序,电话辅导或其组合.
- 通过应用程序,健康检查,指导和问卷在基线和6个月收集的数据.
主要成果:
- 52%的参与者使用了mysnapp移动应用程序;应用程序用户在人口统计学上与非用户相似.
- 应用程序用户更有可能参加实践护士健康检查和电话辅导.
- 在6个月后,应用程序使用与健康素养或饮食改善之间没有发现显著的关联.
结论:
- 在这种低健康素养的人群中,招聘和参与是具有挑战性的.
- 应用程序用户与其他组件的更高参与度表明了对整体干预的更大承诺.
- mysnapp应用程序可以作为多组件健康行为改变计划的参与工具.
相关概念视频
Regression Toward the Mean
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Randomized Experiments
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...


